https://sms.carm.es/ricsmur/handle/123456789/17144 2026-07-12T18:28:27Z https://sms.carm.es/ricsmur/handle/123456789/26724 Área 2. Boletín Informativo del Área de Salud II, 2026, Número 102, julio Servicio Murciano de Salud Actos de aniversario: Exposición de fotografías y mesa de debate 2 ¿ Día el Medioambiente 3 ¿ Family Place 3 Unidad de Patología Tiroidea 4 ¿ Fast Link e infecciosas 4 ¿ Jornadas 5 ¿ Primera residente de Urgencias 6 ¿ Centros IMIB: Cartagena Oeste, Cartagena Este y Mar Menor 7 2026-07-01T00:00:00Z https://sms.carm.es/ricsmur/handle/123456789/26530 Enfermedad de moyamoya: aspectos clínicos, neurorradiológicos, neuropsicolológicos y genéticos Espert, R; Gadea, M; Alino, M; Oltra-Cucarella, Javier; Perpina, C INTRODUCTION: Moyamoya disease (MMD) is an occlusive cerebrovascular disease characterized by progressive stenosis or occlusion in the terminal portion of the bilateral internal carotid arteries, affecting both children and adults. AIM: To conduct a review and update on MMD from a clinical, neuroradiological, neuropsychological and genetic perspective. DEVELOPMENT: In this pathology, which occurs with ischemia or cerebral hemorrhage, an unusual compensatory vascular network (moyamoya vessels) develops at the base of the brain in the form of collateral channels. MMD can present clinically with hemiparesis, dysarthria, aphasia, headache, seizures, visual deficits, syncopes or changes in personality. At the neuropsychological level, and even in the absence of obvious strokes, patients usually present impairment of attention, memory, behavior and executive functions. High resolution angiography and magnetic resonance imaging have been a neuroradiological advance towards an early detection of this disease. At the genetic level, the RING (really interesting new gene) RNF213 has recently been identified, and it is considered the most important genetic risk factor known up to now in the MMD. CONCLUSIONS: MMD is a rare pathology that predominantly affects the frontal lobes. The genetic and neuroradiological advances, in addition to a cognitive profile, contribute to early diagnosis and treatment to improve the quality of life of these patients. 2018-03-01T00:00:00Z https://sms.carm.es/ricsmur/handle/123456789/26522 Batería neuropsicológica breve en la esclerosis múltiple. Baremación normativa estratificada por edad y nivel educativo Duque, Pablo; Oltra-Cucarella, Javier; Fernández, Óscar; Sepulcre, Jorge INTRODUCTION: Interpretation of the performance on cognitive tests for neuropsychological assessment in multiple sclerosis (MS) differs according to the educational level of the examinee. AIMS: To provide normative data for the Brief Neuropsychological Battery (BNB) for MS stratified by age and education, as well as to demonstrate the utility of the battery for discriminating between healthy controls and patients with MS. SUBJECTS AND METHODS: Data from 701 healthy volunteers from the original normative sample were stratified by age and education using regression analyses of standard scores. Performance of the healthy control group was compared to a group of 112 patients with MS. RESULTS: Significant differences on the BNB were found between groups, mainly in tasks of information processing speed, working memory and verbal memory. Age and sex variables did not have a significant effect on the results. CONCLUSIONS: Our data indicate that the BNB for MS is sensitive for identifying cognitive impairments in MS, specifically in tasks measuring working memory. 2017-01-01T00:00:00Z https://sms.carm.es/ricsmur/handle/123456789/26509 ¿A quién le importa la prevención? López-Santiago, Asensio 2024-11-01T00:00:00Z